20 result found: ICD-10-CM Diagnosis Code C55 [convert to ICD-9-CM] Malignant neoplasm of uterus, part unspecified. Cancer of the uterus; Cancer of the uterus, leiomyosarcoma; Cancer of the uterus, sarcoma; Leiomyosarcoma of uterus; Malignant neoplasm of uterus; Primary malignant neoplasm of uterus; Sarcoma of uterus.
Oct 01, 2021 · Z87.19 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z87.19 became effective on October 1, 2021. This is the American ICD-10-CM version of Z87.19 - other international versions of ICD-10 Z87.19 may differ.
2021/2022 ICD-10-CM Index > 'Leiomyosarcoma'. 2021/2022 ICD-10-CM Index.
The ICD-10-CM Alphabetical Index is designed to allow medical coders to look up various medical terms and connect them with the appropriate ICD codes. There are 2 terms under the parent term 'Leiomyosarcoma' in the ICD-10-CM Alphabetical Index . Leiomyosarcoma - see also Neoplasm, connective tissue, malignant.
The 2022 edition of ICD-10-CM Z87.19 became effective on October 1, 2021.
Z77-Z99 Persons with potential health hazards related to family and personal history and certain conditions influencing health status
The 2022 edition of ICD-10-CM Z85.89 became effective on October 1, 2021.
Z77-Z99 Persons with potential health hazards related to family and personal history and certain conditions influencing health status
The 2022 edition of ICD-10-CM Z85.42 became effective on October 1, 2021.
Z77-Z99 Persons with potential health hazards related to family and personal history and certain conditions influencing health status
The 2022 edition of ICD-10-CM Z85.79 became effective on October 1, 2021.
Z77-Z99 Persons with potential health hazards related to family and personal history and certain conditions influencing health status
Z85.831 is a billable diagnosis code used to specify a medical diagnosis of personal history of malignant neoplasm of soft tissue. The code Z85.831 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.#N#The ICD-10-CM code Z85.831 might also be used to specify conditions or terms like history of kaposi's sarcoma, history of malignant mesothelioma, history of malignant neoplasm of peritoneum, history of rhabdomyosarcoma, history of soft tissue sarcoma , intergroup rhabdomyosarcoma study post-surgical clinical group ia: localized tumor, confined to site of origin, completely resected, etc. The code is exempt from present on admission (POA) reporting for inpatient admissions to general acute care hospitals.#N#The code Z85.831 describes a circumstance which influences the patient's health status but not a current illness or injury. The code is unacceptable as a principal diagnosis.
The code is exempt from present on admission (POA) reporting for inpatient admissions to general acute care hospitals. The code Z85.831 describes a circumstance which influences the patient's health status but not a current illness or injury.
Z85.831 is exempt from POA reporting - The Present on Admission ( POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement. Review other POA exempt codes here.
Z77-Z99 Persons with potential health hazards related to family and personal history and certain conditions influencing health status
Z85.05 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.